These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17393727)

  • 1. Immune reactivity of candidate reference materials.
    Fernandez-Rivas M; Aalbers M; Fötisch K; de Heer P; Notten S; Vieths S; van Ree R
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):84-8; discussion 88-90, 100-4. PubMed ID: 17393727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The European Union CREATE project: a model for international standardization of allergy diagnostics and vaccines.
    Chapman MD; Ferreira F; Villalba M; Cromwell O; Bryan D; Becker WM; Fernández-Rivas M; Durham S; Vieths S; van Ree R;
    J Allergy Clin Immunol; 2008 Nov; 122(5):882-889.e2. PubMed ID: 18762328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
    Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a low immunoglobulin E-binding mutant of the timothy grass pollen major allergen Phl p 5a.
    Wald M; Kahlert H; Weber B; Jankovic M; Keller W; Cromwell O; Nandy A; Fiebig H
    Clin Exp Allergy; 2007 Mar; 37(3):441-50. PubMed ID: 17359394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of structure and IgE epitopes by eukaryotic expression of the major Timothy grass pollen allergen, Phl p 1.
    Ball T; Edstrom W; Mauch L; Schmitt J; Leistler B; Fiebig H; Sperr WR; Hauswirth AW; Valent P; Kraft D; Almo SC; Valenta R
    FEBS J; 2005 Jan; 272(1):217-27. PubMed ID: 15634345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy.
    Mittag D; Akkerdaas J; Ballmer-Weber BK; Vogel L; Wensing M; Becker WM; Koppelman SJ; Knulst AC; Helbling A; Hefle SL; Van Ree R; Vieths S
    J Allergy Clin Immunol; 2004 Dec; 114(6):1410-7. PubMed ID: 15577846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of folded recombinant Der p 5, a potential diagnostic marker allergen for house dust mite allergy.
    Weghofer M; Grote M; Dall'Antonia Y; Fernández-Caldas E; Krauth MT; van Hage M; Horak F; Thomas WR; Valent P; Keller W; Valenta R; Vrtala S
    Int Arch Allergy Immunol; 2008; 147(2):101-9. PubMed ID: 18520154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation.
    Vrtala S; Ball T; Spitzauer S; Pandjaitan B; Suphioglu C; Knox B; Sperr WR; Valent P; Kraft D; Valenta R
    J Immunol; 1998 Jun; 160(12):6137-44. PubMed ID: 9637531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The allergen profile of beech and oak pollen.
    Egger C; Focke M; Bircher AJ; Scherer K; Mothes-Luksch N; Horak F; Valenta R
    Clin Exp Allergy; 2008 Oct; 38(10):1688-96. PubMed ID: 18754759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, expression and immunological characterization of full-length timothy grass pollen allergen Phl p 4, a berberine bridge enzyme-like protein with homology to celery allergen Api g 5.
    Dewitt AM; Andersson K; Peltre G; Lidholm J
    Clin Exp Allergy; 2006 Jan; 36(1):77-86. PubMed ID: 16393269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody.
    Flicker S; Steinberger P; Norderhaug L; Sperr WR; Majlesi Y; Valent P; Kraft D; Valenta R
    Eur J Immunol; 2002 Aug; 32(8):2156-62. PubMed ID: 12209627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity.
    Flicker S; Steinberger P; Ball T; Krauth MT; Verdino P; Valent P; Almo S; Valenta R
    J Allergy Clin Immunol; 2006 Jun; 117(6):1336-43. PubMed ID: 16750995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patients.
    Oberhuber C; Ma Y; Wopfner N; Gadermaier G; Dedic A; Niggemann B; Maderegger B; Gruber P; Ferreira F; Scheiner O; Hoffmann-Sommergruber K
    Int Arch Allergy Immunol; 2008; 145(2):94-101. PubMed ID: 17823540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of recombinant major allergens Bet v 1 and Phl p 5a as Ph. Eur. reference standards and validation of ELISA methods for their measurement. Results from feasibility studies.
    Vieths S; Barber D; Chapman M; Costanzo A; Daas A; Fiebig H; Hanschmann KM; Hrabina M; Kaul S; Ledesma A; Moingeon P; Reese G; Schörner C; van Ree R; Weber B; Buchheit KH
    Pharmeur Bio Sci Notes; 2012 Apr; 2012():118-34. PubMed ID: 23327896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of purified Dermatophagoides pteronyssinus allergens and extract by two-dimensional immunoblotting and quantitative immunoglobulin E inhibitions.
    Weghofer M; Thomas WR; Pittner G; Horak F; Valenta R; Vrtala S
    Clin Exp Allergy; 2005 Oct; 35(10):1384-91. PubMed ID: 16238800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoallergenic mutants of Ole e 1, the major olive pollen allergen, as candidates for allergy vaccines.
    Marazuela EG; Rodríguez R; Barber D; Villalba M; Batanero E
    Clin Exp Allergy; 2007 Feb; 37(2):251-60. PubMed ID: 17250698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual reactivity to rBET V1 and rPHL P1 in patients with oral allergy syndrome.
    Marcucci F; Sensi L; Di Cara G; Gidaro G; Incorvaia C; Frati F
    Int J Immunopathol Pharmacol; 2006; 19(1):141-8. PubMed ID: 16569352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of allergic patients' phenotypes with IgE reactivity to recombinant pollen marker allergens.
    Twardosz-Kropfmüller A; Singh MB; Niederberger V; Horak F; Kraft D; Spitzauer S; Valenta R; Swoboda I
    Allergy; 2010 Mar; 65(3):296-303. PubMed ID: 19839972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.